@MarkFordem 13/02/2019 16:29Cambrex Co. (NYSE:CBM) issued its quarterly earnings data on Wednesday, February, 13th. The biotechnology company reported $1.44 EPS for the quarter, topping the Zacks' consensus estimate of $1.32 by $0.12. The biotechnology company had revenue of $212.30 million for the quarter, compared to analysts' expectations of $182.49 million. Cambrex had a return on equity of 22.20% and a net margin of 22.67%. The firm's quarterly revenue was up 16.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.26 earnings per share.NYSE:CBM - Stock Price, News, & Analysis for Cambrex | MarketBeat#1 de 2
@MarkFordem 18/02/2019 20:29Cambrex Corp (CBM) Q4 2018 Earnings Conference Call Transcript -- The Motley Fool#2 de 2
